Engineering antibodies for stability and efficient folding
- PMID: 18071941
- DOI: 10.1007/978-3-540-73259-4_3
Engineering antibodies for stability and efficient folding
Abstract
Antibody variable domains vary widely in their intrinsic thermodynamic stability. Despite the mutual stabilization of the domains in the scFv fragment, most scFv derived from monoclonal antibodies without further engineering show poor to moderate stability. The situation gets more complex for Fab fragments and full-sized antibodies: while the disulfide-linked C(L)/C(H) heterodimer shows very limited thermodynamic stability, its unfolding kinetics are very slow. The same is true for Fab fragments, which, due to this kinetic stabilization, appear to be more stable than their thermodynamic stability suggests. However, suboptimal variable domains can be engineered for improved stability and folding efficiency while preserving their antigen-binding specificity and affinity, either by a limited number of point mutations or by grafting their antigen specificity to superior variable domain frameworks.
Similar articles
-
Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.J Mol Biol. 2005 Apr 8;347(4):773-89. doi: 10.1016/j.jmb.2005.01.053. J Mol Biol. 2005. PMID: 15769469
-
Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.Mol Immunol. 2008 May;45(9):2474-85. doi: 10.1016/j.molimm.2008.01.016. Epub 2008 Mar 3. Mol Immunol. 2008. PMID: 18313757
-
Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.J Mol Biol. 2001 Sep 7;312(1):221-8. doi: 10.1006/jmbi.2001.4915. J Mol Biol. 2001. PMID: 11545598
-
Antibody therapeutics, antibody engineering, and the merits of protein stability.Curr Opin Drug Discov Devel. 2008 Sep;11(5):675-87. Curr Opin Drug Discov Devel. 2008. PMID: 18729019 Review.
-
Kinetic analysis of engineered antibody-antigen interactions.J Mol Recognit. 1994 Mar;7(1):1-7. doi: 10.1002/jmr.300070102. J Mol Recognit. 1994. PMID: 7527233 Review.
Cited by
-
Surface-Functionalized Nanoparticles as Efficient Tools in Targeted Therapy of Pregnancy Complications.Int J Mol Sci. 2019 Jul 25;20(15):3642. doi: 10.3390/ijms20153642. Int J Mol Sci. 2019. PMID: 31349643 Free PMC article. Review.
-
Identifying bottlenecks in transient and stable production of recombinant monoclonal-antibody sequence variants in Chinese hamster ovary cells.Biotechnol Prog. 2012 May-Jun;28(3):846-55. doi: 10.1002/btpr.1542. Epub 2012 May 21. Biotechnol Prog. 2012. PMID: 22467228 Free PMC article.
-
Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horses.Sci Rep. 2023 Mar 10;13(1):4029. doi: 10.1038/s41598-023-31173-y. Sci Rep. 2023. PMID: 36899044 Free PMC article.
-
Computational approaches for rational design of proteins with novel functionalities.Comput Struct Biotechnol J. 2012 Sep 28;2:e201209002. doi: 10.5936/csbj.201209002. eCollection 2012. Comput Struct Biotechnol J. 2012. PMID: 24688643 Free PMC article. Review.
-
High-affinity target binding engineered via fusion of a single-domain antibody fragment with a ligand-tailored SH3 domain.PLoS One. 2012;7(7):e40331. doi: 10.1371/journal.pone.0040331. Epub 2012 Jul 5. PLoS One. 2012. PMID: 22792285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources